Horizon Investments’s iShares Future Exponential Technologies ETF XT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.7K Sell
565
-469
-45% -$36.6K ﹤0.01% 1149
2026
Q1
$70.5K Buy
1,034
+517
+100% +$36.7K ﹤0.01% 1117
2025
Q4
$36.1K Buy
517
+52
+11% +$3.81K ﹤0.01% 1132
2025
Q3
$33.5K Buy
+465
New +$31.5K ﹤0.01% 1013
2018
Q3
Sell
-717,944
Closed -$26M 297
2018
Q2
$26M Buy
717,944
+14,544
+2% +$534K 1.13% 22
2018
Q1
$25.6M Sell
703,400
-41,096
-6% -$1.52M 1.12% 24
2017
Q4
$23.2M Sell
744,496
-19,353
-3% -$678K 1.45% 16
2017
Q3
$23.8M Sell
763,849
-51,649
-6% -$1.71M 1.37% 21
2017
Q2
$25.4M Sell
815,498
-16,560
-2% -$515K 1.51% 16
2017
Q1
$24.7M Buy
+832,058
New +$23.8M 1.64% 17

Other funds holding XT

Horizon Investments's XT Position: Q2 2026 in Review

Horizon Investments reduced its iShares Future Exponential Technologies ETF (XT) stake by 45% in Q2 2026, selling an estimated $36.6K and leaving 565 shares worth $46.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1149.

Horizon Investments first reported a position in XT in Q1 2017 and has held it in 10 quarters since. The position peaked at $26M in Q2 2018. 288 funds tracked by Wall St. Rank hold XT as of Q2 2026.

  • Horizon Investments held 565 shares of iShares Future Exponential Technologies ETF worth $46.7K as of Q2 2026.
  • Horizon Investments sold 469 iShares Future Exponential Technologies ETF shares in Q2 2026, an estimated $36.6K.
  • iShares Future Exponential Technologies ETF made up ﹤0.01% of Horizon Investments's portfolio in Q2 2026, its #1149 holding.
  • Horizon Investments first reported a position in iShares Future Exponential Technologies ETF in Q1 2017 and has held it in 10 quarters since.
  • Horizon Investments's iShares Future Exponential Technologies ETF position peaked at $26M in Q2 2018.
  • 288 funds tracked by Wall St. Rank held iShares Future Exponential Technologies ETF as of Q2 2026.

Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.